This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Owens & Minor Releases 2nd Quarter 2012 Financial Results; Company Plans To Acquire European Healthcare 3PL Business

Owens & Minor, Inc., (NYSE-OMI) today reported financial results for the second quarter ended June 30, 2012, including quarterly revenue of $2.19 billion, improved 2.5% from revenue of $2.13 billion for the second quarter of last year. For the second quarter of 2012, net income was $30.1 million, or $0.48 per diluted share, compared to $29.2 million, or $0.46 per diluted share, for the same period of 2011. Owens & Minor also announced that it has agreed to acquire the Movianto Group (“Movianto”), the healthcare third-party logistics (3PL) business of Celesio AG, effectively launching Owens & Minor into the European healthcare market.

“This quarter’s results highlight many of our traditional areas of strength, such as strong expense and asset management,” said Craig R. Smith, president & chief executive officer of Owens & Minor. “As a team, we continue to work on improving our profitability and advancing our strategic initiatives. We are excited about the Movianto transaction, which will bring together two companies with very similar cultures. We look forward to welcoming the Movianto team to the Owens & Minor family.”

For the second quarter of 2012, operating earnings were $53.2 million, or 2.43% of revenues, improved when compared to operating earnings of $51.0 million, or 2.39% of revenues, for the same period last year. The improvement was driven primarily by lower expenses.

Year-to-Date Results

For the six months ended June 30, 2012, revenue was $4.40 billion, improved $148 million, or 3.5%, when compared to revenue of $4.26 billion for the first six months of 2011. Net income for the first half of 2012 was $59.5 million, or $0.94 per diluted share, improved $1.6 million when compared to net income of $57.9 million, or $0.91 per diluted share in the same period last year. Operating earnings for the year-to-date period were $105.0 million, or 2.39% of revenues, compared to operating earnings of $102.0 million, or 2.40% of revenues, for the same period of 2011.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,131.86 +47.37 0.28%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,838.6430 +8.1730 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs